CRPC Treatment Perspectives

View Web Version

December 4, 2013

E. David Crawford, MD

Improving survival in advanced prostate cancer: The changing role of the urologist

Watch Video →

Charles Ryan, MD

Video summary of the Nov 2013 Lancet article "Abiraterone acetate plus prednisone vs. prednisone alone in chemotherapy-naive men with mCRPC: patient-reported outcome results of a randomised phase 3 trial"

Watch Video →

Adam Kibel, MD summarizes "Metastatic Disease Detection is an Important Cause of Screen Failures in a Phase II Trial Evaluating the Optimal Sequence of Androgen Deprivation Therapy and Sipuleucel-T in Hormone-Naive Patients with Biochemically-Recurrent Prostate Cancer (BRPC)"

Watch Video →

Coming Soon


2217 Fifth Street, Berkeley, CA 94710 USA Update Your Email Preferences \| Unsubscribe \| Forward this Email to a Friend

You are receiving this email because you have chosen to receive emails from UroToday.com. Log in to update your email address or view your email preferences. If you have any questions about your account, please log in to contact us securely and we will be happy to assist you.

CRPC Treatment Perspectives

Login